Searched for
INDIA PHARMA SECTOR GROWTH
FMCG could outshine, IT guidance key this earnings season: Narendra SolankiIndia's Q1 earnings season kicks off with a focus on sectoral performance. While banking, manufacturing, and auto ancillaries are poised fo...- Coal India supply to power sector rises 5.9% in JuneCoal India Limited (CIL) reported a significant uptick in coal supplies, particularly to the power sector, during June and the first quarte...
- Nifty eyes 25,000 as July rally builds; banking, realty and auto lead the charge: Rohit SrivastavaMarket strategist Rohit Srivastava anticipates a strong summer for Indian equities, with the Nifty poised for gains. He highlights banking,...
- US private sector job growth misses expectations in June: ADPUS private sector job growth in June fell short of expectations, adding only 98,000 positions. This marks a slowdown from May's figures, wi...
- India's June factory growth slips to second-weakest since mid-2022 as demand softens, PMI showsIndia's manufacturing sector experienced its second-slowest growth in four years during June, primarily due to a slowdown in demand for goo...
- Bank credit to industry grows at robust 17.5% in May: RBIIndian banks witnessed a significant surge in credit to industries, with a robust 17.5% annual growth in May. This expansion was driven by ...
- India's underperformance sets stage for recovery, says JM Financial's Deepak GuptaIndian equities are showing signs of a potential rebound, with attractive valuations and improved currency stability, according to Deepak G...
- Delayed monsoon may weigh on auto demand, but long-term outlook stays strong: Aditya ShahA delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...
- Sensex rises over 200 points, Nifty above 24,000; Maruti Suzuki shares jump 3%Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...
- IIP growth reached a five-month high of 5.1% in MayIndia's industrial production surged to a five-month high of 5.1% in May, driven by robust growth in electricity and manufacturing sectors....
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- Capacity augmentation, value-added applications critical for making India leader in stainless steel productionWith a growing domestic market and potential in sectors like green hydrogen and pharmaceuticals, India aims to be a manufacturing and innov...
- Auto ancillary sector revenue grew 12.5% in FY26 on volume gains and improved product mix: ReportIndian auto ancillaries witnessed robust revenue growth of 12.5% in FY26, driven by strong volumes and a better product mix. While EBITDA a...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Oil slide powers India's stock benchmarks to longest weekly winning run 7 monthsIndian stock markets achieved their longest winning streak in seven months, with the Nifty 50 and BSE Sensex closing higher. Falling crude ...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
Load More
